ArticleCureus2025
Hyperosmolar Hyperglycemic State With Reversible Encephalopathy in a Young Female on Chronic Steroids and Opioids: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hyperosmolar hyperglycemic state (HHS) is uncommon in young adults and may signal complex metabolic and pharmacologic interactions, particularly in the context of chronic glucocorticoid and opioid exposure. We describe a 22-year-old female with morbid obesity, idiopathic intracranial hypertension treated with ventriculoperitoneal shunting and neuromodulation, chronic high-dose steroid use, and opioid exposure who presented with severe hyperglycemia, dehydration, headache, and transient confusion. Laboratory findings revealed glucose level of 583 mg/dL, calculated osmolality of approximately 318 mOsm/kg, preserved C-peptide indicating severe insulin resistance, and suppressed adrenocorticotropic hormone and cortisol consistent with exogenous steroid-induced hypothalamic-pituitary-adrenal axis suppression. Urine ketones were present, but serum ketones were absent, supporting HHS without ketoacidosis. Neuroimaging excluded acute intracranial pathology. The patient improved with intravenous fluids, insulin therapy, treatment of intercurrent infection, and careful steroid tapering, achieving full neurologic recovery. This case highlights the potential for hyperosmolar neuro-metabolic crisis in young adults with chronic steroid and opioid exposure and emphasizes the importance of considering HHS in atypical populations, particularly when obesity, prolonged glucocorticoid therapy, and central nervous system depressants coexist.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.